LAVA Therapeutics (LVTX) Stock Chart & Stock Price History $1.60 +0.12 (+8.11%) (As of 11/22/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends LAVA Therapeutics Stock Price Performance 5 Day Performance-1.84%1 Month Performance-21.57%3 Month Performance-15.34%6 Month Performance-39.16%Year-To-Date Performance+1.27%1 Year Performance+8.11% Receive LVTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for LAVA Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 917 Trades… Zero Losses? (Ad)As you likely know, the “Trump bump” launched stocks to record highs after he secured his second reelection bid. Now, Trump and his team are coming to gut government regulation – and it’s going to create some incredible market opportunities. But while the masses chase large-cap tech and so-called AI stocks, a small circle of traders are using a strange but tactical method to find a pool of “hidden Trump trades.”Go here to see how you can start accessing these opportunities today LVTX Stock Chart for Saturday, November, 23, 2024 LVTX Chart by TradingView LAVA Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/22/2024$1.48$1.60+8.11%$1.66$1.5030,152 shs$0.0011/21/2024$1.52$1.48-2.63%$1.58$1.4644,251 shs$0.0011/20/2024$1.56$1.52-2.25%$1.59$1.5225,119 shs$38.53 million11/19/2024$1.63$1.56-4.60%$1.65$1.5552,580 shs$0.0011/18/2024$1.57$1.63+3.82%$1.63$1.5458,761 shs$0.0011/15/2024$1.66$1.57-5.42%$1.67$1.5536,515 shs$39.80 million Get the Latest News and Ratings for LVTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for LAVA Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/14/2024$1.70$1.66-2.35%$1.77$1.6536,563 shs$0.0011/13/2024$1.76$1.70-3.41%$1.86$1.6564,384 shs$0.0011/12/2024$1.85$1.76-4.86%$1.81$1.7522,775 shs$44.62 million11/11/2024$1.85$1.85$1.89$1.8229,879 shs$46.90 million11/08/2024$1.84$1.85+0.54%$1.88$1.8411,687 shs$46.90 million11/07/2024$1.90$1.84-3.16%$1.97$1.7960,920 shs$46.64 million11/06/2024$1.82$1.90+4.40%$1.90$1.7829,201 shs$0.0011/05/2024$1.77$1.82+2.82%$1.84$1.759,823 shs$0.0011/04/2024$1.90$1.77-6.84%$1.87$1.7689,681 shs$44.87 million11/01/2024$1.81$1.90+4.97%$1.97$1.7874,527 shs$0.0010/31/2024$1.90$1.81-4.74%$1.88$1.7745,038 shs$45.88 million10/30/2024$1.82$1.90+4.40%$1.93$1.8129,288 shs$48.17 million10/29/2024$2.04$1.82-10.57%$2.01$1.7786,591 shs$46.14 million10/28/2024$2.00$2.04+1.75%$2.06$1.95198,453 shs$51.59 million10/25/2024$2.00$2.00$2.04$1.9680,391 shs$0.0010/24/2024$2.04$2.00-1.96%$2.05$1.9091,536 shs$50.70 million10/23/2024$1.74$2.04+17.24%$2.09$1.75346,293 shs$51.71 million10/22/2024$1.72$1.74+1.13%$1.75$1.7114,850 shs$44.11 million Related Companies 180 Life Sciences Stock Price Chart 4D pharma Stock Price Chart Aesther Healthcare Acquisition Stock Price Chart Ainos Stock Price Chart Alvotech Stock Price Chart Alvotech Stock Price Chart Atlantic Coastal Acquisition Corp. II Stock Price Chart Atlantic Coastal Acquisition Corp. II Stock Price Chart Biofrontera Stock Price Chart biote Stock Price Chart Receive LVTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for LAVA Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:LVTX) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LAVA Therapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Share LAVA Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.